US Stock MarketDetailed Quotes

FOLD Amicus Therapeutics

Watchlist
  • 9.800
  • +0.070+0.72%
Close Dec 20 16:00 ET
  • 9.800
  • 0.0000.00%
Post 20:01 ET
2.93BMarket Cap-28.82P/E (TTM)

Amicus Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Amicus Therapeutics Q3 2024 Earnings Date

Currency：USDNov 6, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
134.96M
141.52M
+6.55M
Beat Est.
+30.40%
+36.73%
+4.86%
EPS
<0.01
-0.02
-0.02
Miss Est.
+101.72%
+71.43%
-1766.67%
Analyst Rating
Strong Buy

Dec 17, 2024

Amicus Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 141.999M--
--2024/Q4-- / 147.374M--
Nov 6, 20242024/Q3141.517M / 134.962M--
Aug 8, 20242024/Q2126.669M / 121.244M--
May 9, 20242024/Q1110.403M / 111.186M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 141.999M--
--2024/Q4-- / 147.374M--
Nov 6, 20242024/Q3141.517M / 134.962M--
Aug 8, 20242024/Q2126.669M / 121.244M--
May 9, 20242024/Q1110.403M / 111.186M--

Unlock Free Earnings Estimates

Amicus Therapeutics Earnings Reports

  • Amicus Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 7 05:11

  • Amicus Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 9 04:48

  • Amicus Therapeutics | 8-K: Amicus Therapeutics Announces Second Quarter 2024 Financial Results and Corporate Updates

    Aug 8 19:04

  • Amicus Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 10 04:08

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 17, 2024

    Strong Buy

    • Buy

      80.00%

    • Hold

      20.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data